Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Raymond D, Bahr"'
Autor:
Raymond D. Bahr
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 13:159-162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57aef76842046b212176a3dc7b4cd71b
https://doi.org/10.1097/hpc.0000000000000029
https://doi.org/10.1097/hpc.0000000000000029
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 16:167-168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b50da2e86f8a996dbc55eadb682692fb
https://doi.org/10.1097/hpc.0000000000000127
https://doi.org/10.1097/hpc.0000000000000127
Autor:
W. Frank Peacock, Gregg C. Fonarow, Douglas S. Ander, Sean P. Collins, Mihai Gheorghiade, J. Douglas Kirk, Gerasimos Filippatos, Deborah B. Diercks, Robin J. Trupp, Brian Hiestand, Ezra A. Amsterdam, William T. Abraham, Gail Dodge, David F. Gaieski, Diane Gurney, Christy O. Hayes, Judd E. Hollander, Kay Holmes, James L. Januzzi, Phillip Levy, Alan Maisel, Chadwick D. Miller, Peter S. Pang, Elsie Selby, Alan B. Storrow, Neal L. Weintraub, Clyde W. Yancy, Raymond D. Bahr, Andra L. Blomkalns, James McCord, Richard M. Nowak, Robert J. Stomel
Publikováno v:
Acute Cardiac Care. 11:3-42
W. Frank Peacock, Cleveland Clinic Foundation, Cleveland, OH Gregg C. Fonarow, Ahmanson-UCLA Cardiomyopathy Center, David Geffen School of Medicine at UCLA, Los Angeles, CAHeart failure is a leadin...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a18dc2bf9b3e279af5e777dc39f0be4
https://doi.org/10.1080/02652040802688690
https://doi.org/10.1080/02652040802688690
Autor:
Yasmin S. Hamirani, Charlene Wenz, Barry Merriman, Daniel Abraham, Ismaila Jibrin, Raymond D. Bahr
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 7:232-238
INTRODUCTION Data comparing efficacy and safety of drug eluting stents (DES), particularly paclitaxel stent with bare metal stents (BMS) in the setting of acute ST elevation myocardial infarction (STEMI) is limited and inconclusive. The aim of our st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::701103a6a948e569d89dd3fea83d238f
https://doi.org/10.1097/hpc.0b013e3181805e0b
https://doi.org/10.1097/hpc.0b013e3181805e0b
Autor:
Raymond D. Bahr
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 3:101-106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac8db686119293dfdb57e76e119b1836
https://doi.org/10.1097/01.hpc.0000137154.94379.0b
https://doi.org/10.1097/01.hpc.0000137154.94379.0b
Autor:
W. Frank Peacock, Jeffrey A. Rosenblatt, Elizabeth S. Fraulo, Matthew T. Roe, James W. Hoekstra, Francis M. Fesmire, Robert H. Christenson, W. Brian Gibler, Hongqiu Yang, Alan B. Storrow, Michael Mollod, E. Magnus Ohman, Raymond D. Bahr
Publikováno v:
American Heart Journal. 146:993-998
Background The acute benefits of platelet glycoprotein IIb/IIIa inhibitors for non-ST–segment elevation acute coronary syndromes (NSTE ACS) remain unclear. Methods In this pilot trial, 311 patients with NSTE ACS were randomly assigned in the emerge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd695d0f522865dc625b8a281b93925d
https://doi.org/10.1016/s0002-8703(03)00517-9
https://doi.org/10.1016/s0002-8703(03)00517-9
Autor:
Raymond D. Bahr
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 2:104-112
Myocardial ischemia is usually manifested clinically as chest pain or chest discomfort. There are exceptions to this, such as presenting symptoms of shortness of breath, nausea, vomiting, weakness, profuse sweating, and so forth, but most of the time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d7a7ce1dc81b4ab74b43b09ddfb3b24
https://doi.org/10.1097/01.hpc.0000077043.34200.74
https://doi.org/10.1097/01.hpc.0000077043.34200.74
Autor:
Raymond D. Bahr
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 1:194-206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b56780137f0b4fec685d93e9e48a81bf
https://doi.org/10.1097/00132577-200209000-00006
https://doi.org/10.1097/00132577-200209000-00006
Autor:
Robert H. Christenson, W. Brian Gibler, Brian Galbut, Raymond D. Bahr, Victor L. Serebruany, Paul A. Gurbel, E. Magnus Ohman, Matthew T. Roe, Kevin P. Bliden
Publikováno v:
Journal of Thrombosis and Thrombolysis. 14:213-219
Background: Receptors other than GP IIb/IIIa may mediate leukocyte-platelet-endothelial interactions that obstruct the microvasculature in acute coronary syndromes (ACS) and cause microinfarcts. The effect of eptifibatide on these receptors was inves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c985787248b33a2e496f2c3878488b40
https://doi.org/10.1023/a:1025048726396
https://doi.org/10.1023/a:1025048726396
Publikováno v:
American Heart Journal. 140:126-133
An estimated 50% of patients with myocardial infarction have prodromal unstable angina. There is controversy over whether prodromal unstable angina identifies a group of patients at lower risk of short- and long-term death and the clinical importance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc983d32b7fdd4bce44c6b0f4eba0a4
https://doi.org/10.1067/mhj.2000.106641
https://doi.org/10.1067/mhj.2000.106641